Scientific Advisory Board
Bernard Churchill, M.D., FRCS(C), FAAP
Dr. Bernard M. Churchill serves as the Judith and Robert Winston Chair in Pediatric Urology and is the founding director of Clark Morrison Children’s Urological Center at the University of California, Los Angeles. He is also former Vice Chair of the Department of Urology at UCLA’s David Geffin School of Medicine and Director of the Urology Residency Program. Dr. Churchill was the prime investigator on a $5.7 million award from the National Institutes of Health, which successfully, for the first time, rapidly identified uropathogens using a DNA Biosensor.
More
J. William Costerton, Ph.D.
Dr. J. William Costerton is the world leader in biofilm research and an expert in microbiology and electron microscopy. During his postdoctoral research work, Dr. Costerton discovered that natural bacterial colonies create their own microhabitats, which become covered with a protective layer of molecules he named “biofilm.” This discovery, published in Scientific American in 1978, led to a new way of thinking about bacteria implicated in chronic diseases and infections.
More
M. Frederick Hawthorne, Ph.D.
Dr. M. Frederick Hawthorne is a world-renowned scientist in the fields of nano and molecular medicine, and a pioneer in boron chemistry. He currently serves as the founding Director of the University of Missouri International Institute of Nano and Molecular Medicine and Professor of Radiology, Chemistry and Physics at the University of Missouri, Columbia.
More
John A. Soderquist, Ph.D.
Dr. John A. Soderquist is a Professor of Organic Chemistry at the University of Puerto Rico and is an internationally recognized thought leader and pioneer in synthetic organic chemistry. Dr. Soderquist brings to NovaBay extensive experience in modern synthetic methodologies utilizing boron, silicon and other Main Group organometallic reagents.
More
Larry K. Truesdale, Ph.D.
Dr. Larry K. Truesdale is Senior Director, External Research & Development Innovation at Pfizer Inc. In this role, Dr. Truesdale assists Pfizer with finding and evaluating new technologies for drug discovery. Prior to this position, Dr. Truesdale served in various management roles at Alanex, Agouron and Warner Lambert, which over the course of three acquisitions ultimately became Pfizer.
More
Roger Whiting, Ph.D.
Dr. Roger Whiting is a co-founder, president and chief scientific officer of Roxro Pharma Inc., a privately owned, virtually organized specialty pharmaceutical company focused on developing innovative treatments for pain. A veteran of the pharmaceutical industry, Dr. Whiting has held a range of scientific and management positions over the past 30 years.
More
